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Conventionalopenharvestofthegreatsaphenousvein(GSV)duringCABGresultsinapproximately7%donor-sitecomplications.
Using endoscopic vein harvesting (EVH) the full GSV length can be harvested through a 3cm incision.This nonsystematicreview
discusses several key issues concerning EVH, based on an extensive Pubmed search. Found studies show that EVH results in
reduced number of wound complications, less postoperative pain, earlier postoperative mobilisation, reduced length of hospital
stay, and is more cost-eﬀective. Initial studies did not ﬁnd signiﬁcant diﬀerences in graft histology, patency, or clinical outcome.
However, in 2009 convincing evidence of inferior histological graft properties became available. Furthermore, an observational
studyshowedthatEVHresulted insigniﬁcantlymoregraftstenosis,wasassociatedwithhighermortality,moremyocardinfarction,
and more reinterventions. Most recent publications could not conﬁrm these ﬁndings, however larger randomisedcontrolled trials
focusing on graft quality are being awaited.
1.Introduction
The great saphenous vein (GSV) is the most commonly used
conduit for coronary artery bypass grafting (CABG). The
referenced standard method of harvesting the GSV is by way
of the open surgical technique. Depending on the required
graft length, the averageincision will vary between 20 and 40
centimetres. However, in the population of patients under-
going CABG, risk factors for impaired wound healing are
overrepresented. Evaluation of 1577 patients that underwent
open GSV harvest for CABG in Maastricht, revealed that
in 1.5% of patients donor-site infections were diagnosed
before discharge [1]. Remarkably this ﬁgure increases to
4.6% at 30 days followup and 7.3% at 90 days followup.
Therefore 80% of the donor-site infections are diagnosed
after discharge, for instance by the patients general physician
or cardiologist. Furthermore wound complications are often
found to be responsible for additional surgery, prolonged
hospital stay, increased hospital costs, and in some cases
permanent disability [1, 2].
The introduction of endoscopic vein harvesting (EVH)
in 1996 seemed a welcome contribution to achieve goals set
in modern cardiac surgery, namely, making cardiac surgery
less invasive and promote earlier recovery after surgery.
Now approximately 15 years after its introduction EVH has
conquered an important place in standard clinical care (80%
oftheCABGproceduresconductedintheUSAuseEVH)[3].
Nevertheless, recentpublicationshaveraised doubtswhether
thequalityanddurabilityofanendoscopicallyharvestedvein
is comparable with a vein harvested in the traditional open
fashion [4, 5]. Is EVH indeed a blessing in the attempts
to make cardiac surgery less invasive or do the recent
publications reveal hidden dangers? This nonsystematic
review article aims to give an overview of 15 years of
clinical experience with EVH, with appropriate attention
for graft quality. Based on a Pubmed search all original
papers, review articles, systematic reviews, and meta-analysis
were collected. For the search several combinations of the
terms endoscopic, minimal invasive, vessel, vein, conduit,
harvest, and harvesting were used. Reports investigating2 Cardiology Research and Practice
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Figure 1: Endoscopic vein harvesting.(a) The ﬁrst step is the identiﬁcation ofthe great saphenous vein (GSV) through a 3-cm incision near
the knee. (b) The next step is the dissection of the vein from the surrounding subcutaneous tissue. (c) After creating a tunnel by means of
CO2 insuﬄation,allsidebranches oftheGSVareidentiﬁed, coagulatedusingdiathermyandtransected. (d)The ﬁnalresult isdemonstrated,
35cm of vein harvested through a 3 cm incision near the knee and a 3-mm counterincision in the groin (arrow).
radial artery harvest, noncardiac use of vein conduits, the
bridging technique,orothernonendoscopictechniqueswere
excluded.
2.Procedure,LearningCurve,and Safety
2.1. The Procedure. During EVH disposable or reusable
systemsare usedtoharvestapproximately35cmoftheupper
leg GSV through a 3cm incision on the medial side of the
knee (Figure 1). By repeating the same procedure in the
other direction, the entire GSV (70cm) can be harvested
through a single incision. Several systems are available, most
frequentlyused are the disposable systems, namely, Vasoview
by Maquet, VirtuoSaph by Terumo, and Clearglide by Sorin.
2.2.Learning Curve. EventhoughEVH systems havebecome
more user-friendly over the years, a signiﬁcant personal
as well as institutional learning curve persists. Analysis of
1348 patients undergoing EVH revealed that the average
procedural time of the ﬁrst 50 cases was 68 minutes, while
the procedural time dropped signiﬁcantly to 23 minutes in
the last 200 cases [6]. In general one can expect a personal
learning curve of 20–100 procedures, depending on surgical
experience.
2.3. Safety. Based on the review of available literature, EVH
can be considered a save operative procedure. The few case
reports describing EVH speciﬁc complications relate to
the use of CO2 insuﬄation, namely, severe hypercapnia,
subclinical CO2 embolization (10.4%), and massive CO2
embolization (0.22%) [6, 7]. An important preventive
measure is reduction of the CO2 insuﬄation pressure, most
importantly not allowing the CO2 pressure to surpass the
central venous pressure.
3.Wound HealingDisturbances
3.1. Noninfectious Healing Disturbances. The most complete
overview article investigating noninfectious wound healing
disturbances is by Athanasiou et al. [29]. This meta-analysis
included 27 studies republished between 1995 and 2002,
within total 4953 patients. Analysis of 12 randomised con-
trolled trials showed a signiﬁcant reduction of noninfectious
wound healing disturbances (wound drainage, haematoma,
oedema,dehiscence,necrosis, needforsurgicaldebridement,
and seroma formation)from13%in openveinharvestto4%
after EVH. The number needed to treat in order to prevent
one complication was only 2 for oedema and 13 for the other
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Diabetes, hyperlipidemia, obesity, female gender, ad-
vanced age, and peripheral vascular disease are known risk
factors for wound healing disturbances after open GSV har-
vest [2, 14]. Research has however shown that particularly
thesehigh-riskpatientsbeneﬁtmostfromminimally invasive
harvest techniques. For example, in patients with diabetes
andobesityno additionalrisk ofwoundhealing disturbances
can be found anymore if EVH is used [14, 15].
3.2. Wound Infections. It is assumed that EVH reduces the
numberofdonor-siteinfectionsbecauseitcauseslesstrauma
to the surrounding tissue, preserves tissue perfusion, and is
less likely to create vital tissue ﬂaps [16]. A meta-analysis
from 2003 included all available randomised controlled
trials that investigated the incidence of donor-site infec-
tions (drainage of pus from the wound, positive wound
cultures, and requirement for additional treatment surgical
or antibiotic treatment) [16]. Eleven randomised controlled
trials, with in total 1156 patients had used endoscopic
techniques. All individual studies found reduced or at least
equal infection rates after EVH. This meta-analysis revealed
that the overall wound infection rate dropped from 13% in
the open harvest group to 3% in the EVH group.
4.PostoperativePainand Mobility
Postoperativepain quantiﬁedusing thevisual analoguescale,
is signiﬁcantly reduced after EVH compared to the tra-
ditional open harvest method [17–20]. Coppoolse et al.
demonstrated that patients undergoing EVH rate their expe-
rience of pain 2 points lower (on a 0–10 scale) throughout
the whole postoperative period and label themselves pain-
free daysearlierthantheircounterpartsthatunderwent open
harvest [20]. It is therefore not surprising that a number
of studies show that patients undergoing EVH are able
to mobilize earlier and are also more mobile at hospital
discharge and 6 weeks after surgery [17, 19, 21].
5.HospitalLengthofStayand Costs
5.1. Hospital Length of Stay (LOS). With the reduction of
wound complications and earlier mobilisation of patients,
it is likely that recovery time and therefore LOS is reduced.
Two independent studies have indeed showed reduction in
LOS in patients undergoing EVH, respectively, 31 and 34%
reduction compared to traditional conduit harvest [21, 22].
Another study found a nonsigniﬁcant increase of LOS in the
EVH group [23]. The remaining 7 available studies inves-
tigating this aspect of EVH, found trends towards reduced
LOS, without signiﬁcant diﬀerences[17, 18, 24–28]. A meta-
analysis from 2004 with in total 1757 patients conﬁrmed
a reduction of LOS if EVH is used [29].
5.2. Hospital Costs. In the Netherlands an average dispos-
able-system costs C 400 per procedure. So a legitimate
question is whether the additional costs of EVH are justiﬁed
by the potential beneﬁts. A controlled trial compared the
total hospital costs of 100 patients undergoing either EVH
or conventional harvest and found no signiﬁcant diﬀerences
[30]. The reduction in costs by EVH that the authors had
expected, was not found because of the longer use of the
operating room on the one hand and failure to reduced
LOS on the other. In 2008, a study became available which
investigated cost-eﬀectiveness [31]. Because data on health-
related quality of life was lacking, postoperative pain and
mobilisation was used as a measure of eﬀectiveness. Proce-
dural costs were calculated based on previous publications
on LOS, operation-time, and prices of the most expensive
EVH system. So it is important to note that costs of
readmissions, outpatient visits related to wound problems
and costs of wound treatments were not included in his
model. Nevertheless, EVH was found to be the most cost-
eﬀective method of vein harvest.
6.CosmeticResultand Qualityof Life
Since the scare after EVH is considerably smaller, it is not
surprising that patients are signiﬁcantly more satisﬁed with
the cosmetic result after EVH then after the traditional
harvest [17, 23]. However this diﬀerence in appreciation,
measured using a visual analog scale from 0–10, is mostly
notable during the ﬁrst postoperative period. Six weeks after
surgery the cosmetic outcome is equally appreciated [17].
Whatever the case may be, no improvement in quality of
life, measured using a Short Form36 questionnaire, has been
demonstrated at 2 and 4 weeks after surgery [30].
7.Graft Qualityand Durability
Suture repairs because of holes or torn side branches of
the endoscopically harvested vein are 3–5 times more often
necessary then after open vein harvest [12, 32]. The presence
of these macroscopic lesions make one presume that the
endoscopic technique inﬂicts more trauma to the vessel
then the conventional open harvest technique. Furthermore,
concerns exist with regards to thermal spread due to
diathermic coagulation of side branches, detrimental eﬀects
of CO2 insuﬄation, and formation of microscopic clots in
the collapsed GSV due to the pressurized working tunnel. It
has been suggested that this last concern can be dealt with by
early systemic heparinization [33].
7.1. Histological Evaluation. Initial studies addressing graft
histology did not ﬁnd diﬀerences in injury to the vascular
wall and found comparable endothelial integrity after EVH
compared to open harvest [17, 19, 27, 34]. One study
even found superior endothelial integrity after EVH [35].
However, in 2009 Boston researchers showed evidence of
injury tothesaphenousveinendotheliumduringendoscopic
harvest [4]. Using three independent techniques (immuno-
histochemistry, western blot, and multiphoton microscopy),
they demonstrated reduced calcium mobilization, nitric
oxide production, and esterase activity and reduced levels
of von Willebrand factor, all signs of impaired structural
and functional viability of saphenous vein endothelium. The
authorsstatethatthefounddetrimentaleﬀectsonsaphenous4 Cardiology Research and Practice
Table 1: Graft quality in terms of graft patency and clinical outcome.
Authors, yr Method N Followup
Patency rate
Clinical outcome (EVH versus open harvest)
% P value
Felisky et al.,
2002 [8] retrospective 380 EVH
340 OVH In-hospital —
— — no signiﬁcant diﬀerences in rate of clinically apparent
early graft failure
Allen et al.,
2003 [9] RCT 54 EVH
58 OVH 5yr —
— — equal 5yr event-free survival (events: death, AMI,
recurrent AP)
Perrault et al.,
2004 [10] RCT, CAG 40 EVH
40 OVH 3m 85%
84% .991 —
Davis et al.,
2004 [11]
retrospective,
CE-CT
51 EVH
50 OVH
3.7yr
0.7yr
95%
95% n.s. —
Yun et al.,
2005 [12] RCT, CAG 100 EVH
100 OVH 6m 68%
70% .584 —
Lopes et al.,
2009 [5]
prospective
nonrandomized,
CAG
1753 EVH
1247 OVH 3yr 73%
77% <.001 associated with higher rates of death, myocardial
infraction, or repeat revascularization
Ouzounian
et al., 2010 [3]
prospective
observational
2004 EVH
3821 OVH 2.6yr —
— — not an independent predictor of in-hospital or midterm
adverse outcome
Kirmani et al.,
2010 [13] case-control 89 EVH
182 OVH
17m
38m
—
— — no diﬀerence in the rates of freedom from angina,
readmissionor need for further antianginals
ns: not signiﬁcant; EVH: endoscopic vein harvesting, OVH: open vein harvesting, CAG: coronary angiogram, RCT: randomized controlled trial; AMI: acute
myocardial infarction; AP: angina pectoris; CE-CT: contrast-enhanced CT.
vein endothelium may lead to decreased graft patency and
worse patient outcome.
7.2. Graft Patency. Only a limited number of studies are
available that give insights into angiographic implication of
possible histological vein injury. Two randomised controlled
trials were not able to show signiﬁcant diﬀerences in patency
rate between patient undergoing EVH or OVH [10, 12]. In
both studies followup was however short, namely, 3 and 6
months. Davis et al. on the other hand, compared patients
who had undergone EVH 3.7 years prior, to patients that
had undergone open harvest 0.7 years earlier [11]. Contrast-
enhancedCTshowedgoodpatencyrateafterEVH,whichdid
not diﬀer from the control group with the shorter followup.
7.3. Clinical Outcome. Studies that investigate clinical out-
come after EVH (e.g., recurrent angina, number of rein-
terventions, recurrent acute myocardial infarction, and
survival) are scarcely available. One retrospective study
compared patients undergoing EVH with a historical control
group [8]. No signiﬁcant diﬀerences in clinically apparent
graft failure could be noted. Allen et al. conducted an RCT
with a fairly small number of patients (112 isolated CABG
patients) and found comparable 5 years event-free survival
between the EVH and open harvest group [9]. If a proper
power analysis was conducted remains unclear, since no
description is provided.
Several months after the Boston group published about
inferior histological properties of endoscopically harvested
vein an important clinical paper was published in the New
England Journal of Medicine. Lopes et al. conducted a sec-
ondary analysis on 3000 patients that had been included in
the PREVENTIVtrial [5]. This phase 3 trial had investigated
the eﬀect of ex vivo treatment of saphenous vein conduits
with Edifoligide and had not found any beneﬁcial eﬀect
on graft patency. In 1753, study subjects the vein graft had
been harvested endoscopically and in the remaining 1247
through open surgery. Comparing the two groups revealed
that patients who underwent EVH had higher rates of vein
graft failure at 12 to 18 months. At 3 years, EVH was
associated with higher death (7.4% versus 5.8%), myocardial
infarction, orrepeatrevascularization. Itisimportant tonote
that the harvest method was not randomly assigned and that
details on harvest technique (e.g., used system, experience
of the endoscopist, upper or lower leg harvest, and heparin
administration) were missing.
A recent observational study compared 5825 patients
of whom 34% had undergone EVH [3]. At a followup
of 2.6 years no correlation between harvest method and
recurrent angina, number of reinterventions, acute coronary
syndrome, heart failure or survival could be found. EVH
was even associated with a reduced number of readmissions
for unstable angina. The most recent publication on clinical
outcomeis a retrospective case control study [13].This study
was also not able to ﬁnd diﬀerences in the rates of freedom
from angina, readmission, need for further antianginals or
overall survival. For an overview of the available clinical
studies see Table 1.
8.Conclusions
The aim of minimally invasive conduit harvest techniques
is to reduce the morbidity and recovery time associated
with the procedure, whilst preserving the quality of the
conduit[36].Aseriesofbeneﬁtsarewellfoundedadequately:
EVH results in less wound healing disturbances, less donor-
site infections, less postoperative pain, earlier postoperative
mobilisation, reduced length of hospital stay, and is likelyCardiology Research and Practice 5
to be cost-eﬀective. However, recent publications question
whethertheconditionofpreservedconduitqualityismet.All
currently available publication addressing graft quality have
important shortcomings, including nonrandomised designs,
nonstandardized harvest methods, small sample sizes, retro-
spective nature, or having only short-term followup. Since
EVH has reached an advanced stage of implementation, and
has become accepted and by patients highly appreciated
by part of standard care, thorough randomised evaluation
has become more diﬃcult. Nevertheless a moral obligation
exists to ensure without any doubt safety and durability
of the endoscopically harvested conduit, since conduit
quality is likely to inﬂuence clinical outcome of CABG, the
golden standard for a considerable portion of patients with
multivessel coronary artery disease. Therefore randomised
controlled trials are necessary to settle this issue indeﬁnitely.
Aim of such a trial should be to show noninferiority of EVH
versus open harvest. Since we now have reason to suspect
clinical implications of possible inferior graft quality based
on the ﬁndings of Lopes et al., the only relevant endpoint
is MACE (Major Adverse Cardiac Events). The comparison
with PCI versus CABG debate is in some part valid. The high
number of covariates inﬂuencing in the primary endpoint
will demand hundreds of study subjects in each study arm.
The study of Lopes et al. also learned us that followup
should be at least one year and that the most interesting
secondary endpoint would be graft patency at one year.
Obviously such a study would be costly, while in this ﬁeld
proﬁt margins are considerably smaller then in the PCI
industry. Willingness of companies to invest large amount of
money in such studies will probably be less. Nevertheless a
randomised controlled trial was initiated by a manufacturer
ofEVH systems, namely, the OPTION study. This study, that
is,asinglecentre,100patienttrial,investigatinggraftpatency
among other endpoint, one year after CABG surgery. Results
ofthisandfutureinitiativeswillbeeagerlyawaited,sincethey
will determine the future of endoscopic vein harvesting.
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